Business Context and Reporting Period
This Form 8-K is a current report filed by 180 Life Sciences Corp. (noting a discrepancy with the metadata "FORUM MARKETS Inc") on September 30, 2022. The registrant is a Delaware corporation with principal executive offices in Palo Alto, California, and its common stock (ATNF) and warrants (ATNFW) are listed on The Nasdaq Stock Market LLC. The company is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance regarding stock listing standards rather than financial performance.
Material Changes
The material event reported is the receipt of a Notification Letter from Nasdaq on September 30, 2022, stating the company is not in compliance with Nasdaq Listing Rule 5550(a)(2). The deficiency is due to the common stock's closing bid price remaining below $1.00 per share for 30 consecutive business days (August 18, 2022, to September 29, 2022).
Guidance, Outlook, and Risks
- Compliance Timeline: The company has 180 calendar days, until March 29, 2023, to regain compliance.
- Remediation Requirement: To comply, the stock must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days.
- Secondary Compliance Period: If the initial deadline is missed, an additional 180 days may be granted if the company meets initial listing criteria and notifies Nasdaq of its intent to cure the deficiency, potentially via a reverse stock split.
- Delisting Risk: Failure to regain compliance during the second period will result in delisting, subject to an appeal process.
- Management Action: Management intends to monitor the bid price and may consider available options, including a reverse stock split, to regain compliance.
Investor Verification Checklist
- Verify the current trading price of ATNF to assess proximity to the $1.00 threshold.
- Monitor upcoming press releases for announcements regarding a reverse stock split.
- Review the company's cash position in recent 10-Q or 10-K filings to determine if it has sufficient liquidity to sustain operations if delisting occurs.
- Confirm the exact date of the next Nasdaq compliance deadline (March 29, 2023).